EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI

PURPOSE: Mutations in the epidermal growth factor receptor (EGFR) have been confirmed as predictors of the efficacy of treatment with EGFR-tyrosine kinase inhibitors (TKIs). We investigated whether polymorphisms of the EGFR gene were associated with clinical outcomes in non-small cell lung cancer (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Minkyu, Cho, Byoung Chul, Lee, Chul Ho, Park, Hyung Soon, Kang, Young Ae, Kim, Se Kyu, Chang, Joon, Kim, Dae Jun, Rha, Sun Young, Kim, Joo Hang, Lee, Ji Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481391/
https://www.ncbi.nlm.nih.gov/pubmed/23074112
http://dx.doi.org/10.3349/ymj.2012.53.6.1128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481391/
https://www.ncbi.nlm.nih.gov/pubmed/23074112
http://dx.doi.org/10.3349/ymj.2012.53.6.1128

Ejemplares similares